Heart failure (HF) is a growing global health concern that affects more than 20 million people worldwide. With an ever-growing segment of the population over the age of 65, the prevalence of HF and its associated costs are expected to increase exponentially over the next decade. Advances in the understanding of the pathophysiology and treatment of HF have resulted in the ability to enhance both the quantity and the quality of life of patients with HF. This article reviews the current understanding of the pathophysiology, cause, classification, and treatment of HF and describes areas of uncertainty that demand future study.
Keywords: ACE inhibitors; Ejection fraction; HFrEF; Heart failure; Neurohormonal blockade; Treatment; β-Blockers.
Copyright © 2016 Elsevier Inc. All rights reserved.